Bone Marrow Transplant Market Analysis by Autologous and Allogeneic Transplant Type
Higher Prevalence of Cancers like Leukemia and Lymphoma, the Rising Geriatric Population, and Improved Gene-Based and Stem Cell Replacement Therapies are Garnering Market Growth. FMI Taps the Data
The bone marrow transplant market is anticipated to flourish at an average CAGR of 3.4% between 2023 and 2033. The market is expected to hold a market share of US$ 14.86 billion by 2033, while the market is likely to reach a value of US$ 10.65 billion in 2023. A historical CAGR of 2.5% has been recorded by the experts of Future Market Insights for the market concerned.
The hematopoietic stem cell is a soft vascular tissue in the interiors of long bones, and a bone marrow transplant is identified as the procedure to replace the damaged or destroyed bone marrow with healthy bone marrow stem cells.
Attributes
Details
Bone Marrow Transplant Market CAGR (2023 to 2033)
3.4%
Bone Marrow Transplant Market Size (2023)
US$ 10.65 billion
Bone Marrow Transplant Market Size (2033)
US$ 14.86 billion
The bone marrow transplant procedure is prescribed for the treatment of advanced stages of leukemia, Hodgkin, and non-Hodgkin lymphomas, multiple myeloma, aplastic and sickle cell anemia, thalassemia, and other diseases. Increasing awareness, combined with an increase in initiatives run by healthcare practitioners, is majorly responsible for the global growth of the market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Market Scenario Analysis Potential Drivers and Restraints
The market is anticipated to have mixed dynamics contributing to the bearish propulsion of the bone marrow transplant market. Several factors impacting the expansion of the market are identified during the study.
Besides the factors influencing growth, it is also identified that certain aspects can limit growth and curb the pace of growth further in the market.
Drivers:
The key factor affecting the bone marrow transplant industry is the surge in the prevalence of blood cancer and other blood-related diseases. The statistics predicted by the experts of FMI are anticipated to help the forum propel over the forecast period.
The growing incidences of non-Hodgkin and Hodgkin lymphoma, thalassemia, and leukemia, along with the common bone marrow diseases around the world, the developments in technology, and the enhancement of the healthcare infrastructure are likely to drive the market in the long run.
A steep increase in the development of stem cell cryopreservation, identified as the need of the hour, is majorly contributing to the bone marrow transplant market and is likely to gain further traction in the upcoming years.
An increase in research and development activities is projected to boost the market, and new products are being launched that may help the industry flourish over the forecast period.
A rise in funding for logistic services and growing per capita healthcare expenses are expected to propel the market's growth.
Restraints:
It is identified that there is a high expenditure associated with the treatment, and the high cost of bone marrow transplant is likely to serve as a deterring factor for the bone marrow transplant market, as a large section of the populace cannot afford such expensive treatment of the diseases.
There is a shortage of bone marrow donors, which is an aspect responsible for the impeding growth of the bone marrow transplant market in the near future.
The lack of reimbursement policies for organ transplantation procedures in emerging economies and developed countries is expected to hamper the growth of the industry during the period.
Country-wise Insights
Country
Revenue Share % (2022)
United States
30.3%
Germany
11.9%
Japan
2/0%
North America
32.3%
Europe
53.1%
Country
CAGR % (2023 to 2033)
China
4.2%
India
3.4%
United Kingdom
2.4%
Australia
3.1%
Overview of the North America Bone Marrow Transplant Market
North America is projected to secure steady bone marrow transplant market growth during the forecast period. The region cumulatively held 32.3% market share of the global bone marrow transplant market in 2022.
The factors attributing to the growth can be mentioned as follows:
There is a growth in the healthcare infrastructure of North America; capital expenditures are initiated by the key players prevailing in this region, coupled with an installed base for different kinds of products for the bone marrow transplant market.
It is anticipated that the North American region is having favorable regulatory scenarios that are likely to impact the bone marrow transplant market positively.
European Region Bolstering the Global Bone Marrow Transplant Market
Europe is projected to dominate the global market for bone marrow transplants during the forecast period. At present, Europe holds 53.1% of the total market share for bone marrow transplants worldwide in 2022.
The reasons owing for such extensive market expansion are mentioned below:
The increasing geriatric population of Europe is widely driving the bone marrow transplant market as they are more prone to severe diseases.
The innovative healthcare systems have introduced bone marrow transplants in their contributions and the state-of-the-art public facilities, which may further boost the growth of the bone marrow transplant market in the region during the forecast period.
New technology penetration in Europe is another factor boosting the concerned market of the region.
Find your sweet spots for generating winning opportunities in this market.
Categorical Analysis
Category
By Transplant Type
Leading Segment
Autologous
Market Share (2022)
54.5%
Category
By End User
Leading Segment
Hospital
Market Share (2022)
90.3%
Start-up Ecosystem
The start-ups in the bone marrow transplant market are indulging in collaborations and continually making innovations to stem cell transplant procedures to further make it convenient and cost-efficient for the population.
Company Name
Magenta Therapeutics, Cambridge (United States)
Total Funding
US$ 151 million
Description
Developed stem cell-based therapies for autoimmune disease, genetic blood disorders, and cancer. The company has developed stem cell transplants by using targeted antibodies, stem cell harvesting using new biologic agents, and increasing stem cell numbers by targeting self-renewal pathways.
Company Name
Kiadis Pharma, Amsterdam (Netherlands)
Total Funding
US$ 33 million
Description
Kiadis Pharma is a developer of therapeutic solutions for hematopoietic stem cell transplants. It is focused on developing solutions for complications and limitations of hematopoietic stem cell transplants (HSCT) in blood cancer patients. The company uses all depleted T-cell immunotherapeutics (ATIR) to support the patient’s newly transplanted immune system before it becomes fully functional. This enables better acceptance of even haploidentical (or lower) stem cell donors. Kiadis is investigating the use of ATIR in leukemia and thalassemia.
Company Name
Talaris, Boston
Total Funding
US$ 215 million
Description
Talaris Therapeutics is involved in developing single-dose cell therapy to treat living donor kidney transplant tolerance. They have developed a proprietary technology that allows candidates for bone marrow transplants to receive hematopoietic stem cells (HSCs). The lead candidate, FCR001, is in phase III clinical trial, which is being investigated for living donor kidney transplant tolerance.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Competitive Landscape
The bone marrow transplant market is highly competitive and consists of several leading players. To increase their global market presence, market leaders are engaging in various product launches, mergers and acquisitions, and development activities focusing on orthopedic surgical treatments.
Recent Developments
Some Recent Developments Identified in the Analysis are:
In May 2020, Gamida Cell Ltd., an advanced cell therapy company committed to finding cures for blood cancer and serious blood diseases, declared positive topline results from its Phase 3 clinical study evaluating the safety and efficacy of omidubicel, investigational advanced cell therapy in development as a potentially life-saving treatment option for patients in need of bone marrow transplant.
In November 2019, Lonza Group Ltd. partnered with Cryoport, Inc. in the cell and gene therapy field and across Lonza's 'vein-to-vein' delivery network.
In September 2017, Inotek Pharmaceuticals entered into a definitive merger agreement with Rocket Pharmaceuticals, a United States-based gene therapy company.
Key Players
Merck Millipore Corporation
Sanofi-Aventis LLC.
AllCells LLC.
STEMCELL Technologies
ATCC Inc.
Hemacare Corporation
Cellular Dynamics International
ReachBio LLC.
Conversant Bio ABM Inc.
PromoCell GmbH
Cruline Human biospecimen PRO
Lifeline Cell Technology
Mesoblast Ltd.
Key Segments Covered
By Transplant Type:
Autologous
Allogeneic
By Disease Indication:
Leukemia
Lymphoma
Myeloma
Others (anemia, thalassemia, etc.)
By End User:
Hospitals
Multispecialty Clinics
Ambulatory Surgical Centers
Others
Key Regions Covered:
North America
United States
Canada
Latin America
Brazil
Mexico
Rest of Latin America
Europe
Germany
United Kingdom
France
Spain
Russia
Rest of Europe
Japan
Asia Pacific Excluding Japan
China
India
Malaysia
Singapore
Australia
Rest of Asia Pacific Excluding Japan (APEJ)
The Middle East and Africa
GCC Countries
Israel
South Africa
Middle East and Africa (MEA)
Frequently Asked Questions
How Significant Is the Current Market?
The market is anticipated to be valued at US$ 10.65 billion in 2023.
How Has the Market Developed in The Past?
The global market advanced at a 2.5% HCAGR from 2018 to 2022.
What Is the Projected Market Growth Between 2023 And 2033?
Up until 2033, the market is anticipated to thrive at a CAGR of 3.4%.
How Much of The Market Is Accounted for By the United States?
Potentially holding 32.3% of the market in North America.
What is The Market Share of Europe?
The market has been dominated by Europe, 53.1%.
What Will the Market Be Worth In 2033?
By 2033, the market is anticipated to be worth US$14.86 billion.
What Is the Prominent Transplant Type on The Market?
The autologous category to escalate to a market share of 54.5% in 2023.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Transplant Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Transplant Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Transplant Type, 2023 to 2033
5.3.1. Autologous
5.3.2. Allogeneic
5.4. Y-o-Y Growth Trend Analysis By Transplant Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Transplant Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Disease Indication
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Disease Indication, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Disease Indication, 2023 to 2033
6.3.1. Leukemia
6.3.2. Lymphoma
6.3.3. Myeloma
6.3.4. Others
6.4. Y-o-Y Growth Trend Analysis By Disease Indication, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Disease Indication, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End-User , 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-User , 2023 to 2033
7.3.1. Hospitals
7.3.2. Multispecialty Clinics
7.3.3. Ambulatory Surgical Centers
7.3.4. Others
7.4. Y-o-Y Growth Trend Analysis By End-User , 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End-User , 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA.
9.2.1.2. Canada
9.2.2. By Transplant Type
9.2.3. By Disease Indication
9.2.4. By End-User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Transplant Type
9.3.3. By Disease Indication
9.3.4. By End-User
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Transplant Type
10.2.3. By Disease Indication
10.2.4. By End-User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Transplant Type
10.3.3. By Disease Indication
10.3.4. By End-User
10.4. Key Takeaways
11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom.
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Transplant Type
11.2.3. By Disease Indication
11.2.4. By End-User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Transplant Type
11.3.3. By Disease Indication
11.3.4. By End-User
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Transplant Type
12.2.3. By Disease Indication
12.2.4. By End-User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Transplant Type
12.3.3. By Disease Indication
12.3.4. By End-User
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Transplant Type
13.2.3. By Disease Indication
13.2.4. By End-User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Transplant Type
13.3.3. By Disease Indication
13.3.4. By End-User
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Transplant Type
14.2.3. By Disease Indication
14.2.4. By End-User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Transplant Type
14.3.3. By Disease Indication
14.3.4. By End-User
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Transplant Type
15.2.3. By Disease Indication
15.2.4. By End-User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Transplant Type
15.3.3. By Disease Indication
15.3.4. By End-User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA.
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Transplant Type
16.1.2.2. By Disease Indication
16.1.2.3. By End-User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Transplant Type
16.2.2.2. By Disease Indication
16.2.2.3. By End-User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Transplant Type
16.3.2.2. By Disease Indication
16.3.2.3. By End-User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Transplant Type
16.4.2.2. By Disease Indication
16.4.2.3. By End-User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Transplant Type
16.5.2.2. By Disease Indication
16.5.2.3. By End-User
16.6. United Kingdom.
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Transplant Type
16.6.2.2. By Disease Indication
16.6.2.3. By End-User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Transplant Type
16.7.2.2. By Disease Indication
16.7.2.3. By End-User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Transplant Type
16.8.2.2. By Disease Indication
16.8.2.3. By End-User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Transplant Type
16.9.2.2. By Disease Indication
16.9.2.3. By End-User
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Transplant Type
16.10.2.2. By Disease Indication
16.10.2.3. By End-User
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Transplant Type
16.11.2.2. By Disease Indication
16.11.2.3. By End-User
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Transplant Type
16.12.2.2. By Disease Indication
16.12.2.3. By End-User
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Transplant Type
16.13.2.2. By Disease Indication
16.13.2.3. By End-User
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Transplant Type
16.14.2.2. By Disease Indication
16.14.2.3. By End-User
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Transplant Type
16.15.2.2. By Disease Indication
16.15.2.3. By End-User
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Transplant Type
16.16.2.2. By Disease Indication
16.16.2.3. By End-User
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Transplant Type
16.17.2.2. By Disease Indication
16.17.2.3. By End-User
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Transplant Type
16.18.2.2. By Disease Indication
16.18.2.3. By End-User
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Transplant Type
16.19.2.2. By Disease Indication
16.19.2.3. By End-User
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Transplant Type
16.20.2.2. By Disease Indication
16.20.2.3. By End-User
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Transplant Type
16.21.2.2. By Disease Indication
16.21.2.3. By End-User
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Transplant Type
16.22.2.2. By Disease Indication
16.22.2.3. By End-User
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Transplant Type
16.23.2.2. By Disease Indication
16.23.2.3. By End-User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Transplant Type
17.3.3. By Disease Indication
17.3.4. By End-User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Lonza Group Ltd.
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Merck Millipore Corporation
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Sanofi-Aventis LLC.
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. AllCells LLC.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. STEMCELL Technologies
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. ATCC Inc.
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Hemacare Corporation
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Cellular Dynamics International
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. ReachBio LLC.
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. Conversant Bio, ABM Inc.
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.11. PromoCell GmbH
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.12. Cruline Human biospecimen PRO
18.1.12.1. Overview
18.1.12.2. Product Portfolio
18.1.12.3. Profitability by Market Segments
18.1.12.4. Sales Footprint
18.1.12.5. Strategy Overview
18.1.12.5.1. Marketing Strategy
18.1.13. Lifeline Cell Technology
18.1.13.1. Overview
18.1.13.2. Product Portfolio
18.1.13.3. Profitability by Market Segments
18.1.13.4. Sales Footprint
18.1.13.5. Strategy Overview
18.1.13.5.1. Marketing Strategy
18.1.14. Mesoblast Ltd.
18.1.14.1. Overview
18.1.14.2. Product Portfolio
18.1.14.3. Profitability by Market Segments
18.1.14.4. Sales Footprint
18.1.14.5. Strategy Overview
18.1.14.5.1. Marketing Strategy
19. Assumptions & Acronyms Used20. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033
Table 2: Global Market Value (US$ Million) Forecast by Transplant Type, 2018 to 2033
Table 3: Global Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033
Table 4: Global Market Value (US$ Million) Forecast by End-User , 2018 to 2033
Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 6: North America Market Value (US$ Million) Forecast by Transplant Type, 2018 to 2033
Table 7: North America Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033
Table 8: North America Market Value (US$ Million) Forecast by End-User , 2018 to 2033
Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 10: Latin America Market Value (US$ Million) Forecast by Transplant Type, 2018 to 2033
Table 11: Latin America Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033
Table 12: Latin America Market Value (US$ Million) Forecast by End-User , 2018 to 2033
Table 13: Western Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 14: Western Europe Market Value (US$ Million) Forecast by Transplant Type, 2018 to 2033
Table 15: Western Europe Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033
Table 16: Western Europe Market Value (US$ Million) Forecast by End-User , 2018 to 2033
Table 17: Eastern Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 18: Eastern Europe Market Value (US$ Million) Forecast by Transplant Type, 2018 to 2033
Table 19: Eastern Europe Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033
Table 20: Eastern Europe Market Value (US$ Million) Forecast by End-User , 2018 to 2033
Table 21: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 22: South Asia and Pacific Market Value (US$ Million) Forecast by Transplant Type, 2018 to 2033
Table 23: South Asia and Pacific Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033
Table 24: South Asia and Pacific Market Value (US$ Million) Forecast by End-User , 2018 to 2033
Table 25: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 26: East Asia Market Value (US$ Million) Forecast by Transplant Type, 2018 to 2033
Table 27: East Asia Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033
Table 28: East Asia Market Value (US$ Million) Forecast by End-User , 2018 to 2033
Table 29: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 30: Middle East and Africa Market Value (US$ Million) Forecast by Transplant Type, 2018 to 2033
Table 31: Middle East and Africa Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033
Table 32: Middle East and Africa Market Value (US$ Million) Forecast by End-User , 2018 to 2033
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Transplant Type, 2023 to 2033
Figure 2: Global Market Value (US$ Million) by Disease Indication, 2023 to 2033
Figure 3: Global Market Value (US$ Million) by End-User , 2023 to 2033
Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033
Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 8: Global Market Value (US$ Million) Analysis by Transplant Type, 2018 to 2033
Figure 9: Global Market Value Share (%) and BPS Analysis by Transplant Type, 2023 to 2033
Figure 10: Global Market Y-o-Y Growth (%) Projections by Transplant Type, 2023 to 2033
Figure 11: Global Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033
Figure 12: Global Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033
Figure 13: Global Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033
Figure 14: Global Market Value (US$ Million) Analysis by End-User , 2018 to 2033
Figure 15: Global Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033
Figure 16: Global Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033
Figure 17: Global Market Attractiveness by Transplant Type, 2023 to 2033
Figure 18: Global Market Attractiveness by Disease Indication, 2023 to 2033
Figure 19: Global Market Attractiveness by End-User , 2023 to 2033
Figure 20: Global Market Attractiveness by Region, 2023 to 2033
Figure 21: North America Market Value (US$ Million) by Transplant Type, 2023 to 2033
Figure 22: North America Market Value (US$ Million) by Disease Indication, 2023 to 2033
Figure 23: North America Market Value (US$ Million) by End-User , 2023 to 2033
Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033
Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 28: North America Market Value (US$ Million) Analysis by Transplant Type, 2018 to 2033
Figure 29: North America Market Value Share (%) and BPS Analysis by Transplant Type, 2023 to 2033
Figure 30: North America Market Y-o-Y Growth (%) Projections by Transplant Type, 2023 to 2033
Figure 31: North America Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033
Figure 32: North America Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033
Figure 33: North America Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033
Figure 34: North America Market Value (US$ Million) Analysis by End-User , 2018 to 2033
Figure 35: North America Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033
Figure 36: North America Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033
Figure 37: North America Market Attractiveness by Transplant Type, 2023 to 2033
Figure 38: North America Market Attractiveness by Disease Indication, 2023 to 2033
Figure 39: North America Market Attractiveness by End-User , 2023 to 2033
Figure 40: North America Market Attractiveness by Country, 2023 to 2033
Figure 41: Latin America Market Value (US$ Million) by Transplant Type, 2023 to 2033
Figure 42: Latin America Market Value (US$ Million) by Disease Indication, 2023 to 2033
Figure 43: Latin America Market Value (US$ Million) by End-User , 2023 to 2033
Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033
Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 48: Latin America Market Value (US$ Million) Analysis by Transplant Type, 2018 to 2033
Figure 49: Latin America Market Value Share (%) and BPS Analysis by Transplant Type, 2023 to 2033
Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Transplant Type, 2023 to 2033
Figure 51: Latin America Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033
Figure 52: Latin America Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033
Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033
Figure 54: Latin America Market Value (US$ Million) Analysis by End-User , 2018 to 2033
Figure 55: Latin America Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033
Figure 57: Latin America Market Attractiveness by Transplant Type, 2023 to 2033
Figure 58: Latin America Market Attractiveness by Disease Indication, 2023 to 2033
Figure 59: Latin America Market Attractiveness by End-User , 2023 to 2033
Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 61: Western Europe Market Value (US$ Million) by Transplant Type, 2023 to 2033
Figure 62: Western Europe Market Value (US$ Million) by Disease Indication, 2023 to 2033
Figure 63: Western Europe Market Value (US$ Million) by End-User , 2023 to 2033
Figure 64: Western Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 65: Western Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 66: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 67: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 68: Western Europe Market Value (US$ Million) Analysis by Transplant Type, 2018 to 2033
Figure 69: Western Europe Market Value Share (%) and BPS Analysis by Transplant Type, 2023 to 2033
Figure 70: Western Europe Market Y-o-Y Growth (%) Projections by Transplant Type, 2023 to 2033
Figure 71: Western Europe Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033
Figure 72: Western Europe Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033
Figure 73: Western Europe Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033
Figure 74: Western Europe Market Value (US$ Million) Analysis by End-User , 2018 to 2033
Figure 75: Western Europe Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033
Figure 76: Western Europe Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033
Figure 77: Western Europe Market Attractiveness by Transplant Type, 2023 to 2033
Figure 78: Western Europe Market Attractiveness by Disease Indication, 2023 to 2033
Figure 79: Western Europe Market Attractiveness by End-User , 2023 to 2033
Figure 80: Western Europe Market Attractiveness by Country, 2023 to 2033
Figure 81: Eastern Europe Market Value (US$ Million) by Transplant Type, 2023 to 2033
Figure 82: Eastern Europe Market Value (US$ Million) by Disease Indication, 2023 to 2033
Figure 83: Eastern Europe Market Value (US$ Million) by End-User , 2023 to 2033
Figure 84: Eastern Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 85: Eastern Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 88: Eastern Europe Market Value (US$ Million) Analysis by Transplant Type, 2018 to 2033
Figure 89: Eastern Europe Market Value Share (%) and BPS Analysis by Transplant Type, 2023 to 2033
Figure 90: Eastern Europe Market Y-o-Y Growth (%) Projections by Transplant Type, 2023 to 2033
Figure 91: Eastern Europe Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033
Figure 92: Eastern Europe Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033
Figure 93: Eastern Europe Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033
Figure 94: Eastern Europe Market Value (US$ Million) Analysis by End-User , 2018 to 2033
Figure 95: Eastern Europe Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033
Figure 96: Eastern Europe Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033
Figure 97: Eastern Europe Market Attractiveness by Transplant Type, 2023 to 2033
Figure 98: Eastern Europe Market Attractiveness by Disease Indication, 2023 to 2033
Figure 99: Eastern Europe Market Attractiveness by End-User , 2023 to 2033
Figure 100: Eastern Europe Market Attractiveness by Country, 2023 to 2033
Figure 101: South Asia and Pacific Market Value (US$ Million) by Transplant Type, 2023 to 2033
Figure 102: South Asia and Pacific Market Value (US$ Million) by Disease Indication, 2023 to 2033
Figure 103: South Asia and Pacific Market Value (US$ Million) by End-User , 2023 to 2033
Figure 104: South Asia and Pacific Market Value (US$ Million) by Country, 2023 to 2033
Figure 105: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 106: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 107: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 108: South Asia and Pacific Market Value (US$ Million) Analysis by Transplant Type, 2018 to 2033
Figure 109: South Asia and Pacific Market Value Share (%) and BPS Analysis by Transplant Type, 2023 to 2033
Figure 110: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Transplant Type, 2023 to 2033
Figure 111: South Asia and Pacific Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033
Figure 112: South Asia and Pacific Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033
Figure 113: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033
Figure 114: South Asia and Pacific Market Value (US$ Million) Analysis by End-User , 2018 to 2033
Figure 115: South Asia and Pacific Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033
Figure 116: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033
Figure 117: South Asia and Pacific Market Attractiveness by Transplant Type, 2023 to 2033
Figure 118: South Asia and Pacific Market Attractiveness by Disease Indication, 2023 to 2033
Figure 119: South Asia and Pacific Market Attractiveness by End-User , 2023 to 2033
Figure 120: South Asia and Pacific Market Attractiveness by Country, 2023 to 2033
Figure 121: East Asia Market Value (US$ Million) by Transplant Type, 2023 to 2033
Figure 122: East Asia Market Value (US$ Million) by Disease Indication, 2023 to 2033
Figure 123: East Asia Market Value (US$ Million) by End-User , 2023 to 2033
Figure 124: East Asia Market Value (US$ Million) by Country, 2023 to 2033
Figure 125: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 126: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 127: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 128: East Asia Market Value (US$ Million) Analysis by Transplant Type, 2018 to 2033
Figure 129: East Asia Market Value Share (%) and BPS Analysis by Transplant Type, 2023 to 2033
Figure 130: East Asia Market Y-o-Y Growth (%) Projections by Transplant Type, 2023 to 2033
Figure 131: East Asia Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033
Figure 132: East Asia Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033
Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033
Figure 134: East Asia Market Value (US$ Million) Analysis by End-User , 2018 to 2033
Figure 135: East Asia Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033
Figure 136: East Asia Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033
Figure 137: East Asia Market Attractiveness by Transplant Type, 2023 to 2033
Figure 138: East Asia Market Attractiveness by Disease Indication, 2023 to 2033
Figure 139: East Asia Market Attractiveness by End-User , 2023 to 2033
Figure 140: East Asia Market Attractiveness by Country, 2023 to 2033
Figure 141: Middle East and Africa Market Value (US$ Million) by Transplant Type, 2023 to 2033
Figure 142: Middle East and Africa Market Value (US$ Million) by Disease Indication, 2023 to 2033
Figure 143: Middle East and Africa Market Value (US$ Million) by End-User , 2023 to 2033
Figure 144: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033
Figure 145: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 146: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 147: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 148: Middle East and Africa Market Value (US$ Million) Analysis by Transplant Type, 2018 to 2033
Figure 149: Middle East and Africa Market Value Share (%) and BPS Analysis by Transplant Type, 2023 to 2033
Figure 150: Middle East and Africa Market Y-o-Y Growth (%) Projections by Transplant Type, 2023 to 2033
Figure 151: Middle East and Africa Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033
Figure 152: Middle East and Africa Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033
Figure 153: Middle East and Africa Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033
Figure 154: Middle East and Africa Market Value (US$ Million) Analysis by End-User , 2018 to 2033
Figure 155: Middle East and Africa Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033
Figure 156: Middle East and Africa Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033
Figure 157: Middle East and Africa Market Attractiveness by Transplant Type, 2023 to 2033
Figure 158: Middle East and Africa Market Attractiveness by Disease Indication, 2023 to 2033
Figure 159: Middle East and Africa Market Attractiveness by End-User , 2023 to 2033
Figure 160: Middle East and Africa Market Attractiveness by Country, 2023 to 2033
